Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative for Precision Medicine LeadersDelray Beach, FL, Feb. 24, 2026 (GLOBE ...
Background Monogenic disorders are a major cause of fetal structural anomalies. Most genetic diagnoses involve de novo, biallelic or X linked variants; however, inherited variants in autosomal ...
Background Balanced translocation (BT) carriers have a high risk of recurrent miscarriage and abnormal offspring due to unbalanced gamete production. Clinical genetic testing often fails to detect BTs ...
The rapid evolution of mass spectrometry (MS) has established proteomics as a cornerstone of functional genomics, necessitating sophisticated proteomics data analysis and bioinformatics tools to ...
Rising Pharmaceutical R&D Spending, Expanding Clinical Diagnostics Demand, and Rapid Advancement in Mass Spectrometry and Multi-Omics Technologies Accelerate Global Proteomics Market Growth.Austin, ...
Single-cell omics is a transformative area within life sciences, enabling researchers to untangle cellular heterogeneity, uncover developmental lineages, ...
Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and ...
You don’t have to miss the innovation because you missed the conference. In this ASHG25 workshop replay, we unveil a new automated microarray workflow that enables sample-to-report in ...
Bioinformatics is a computational and analytical technique that applies algorithms, statistical methods, and database technologies to the acquisition, storage, processing, and interpretation of ...
From mature companies to innovative startups, the Center of Excellence in Bioinformatics and Life Sciences (CBLS) helps biomedical and life sciences companies grow and succeed. We provide research ...
Omics-driven insights into tumor microenvironment determinants of immunotherapy response in melanoma
Immunotherapy has revolutionized cancer treatment, yet response rates remain highly variable across tumor types and individual patients. Increasing evidence ...
How to make racial representation in GWAS more proportionate? Thought leaders from Africa, South Korea, and New Zealand, discuss the causes, challenges, and action being taken to close the gap. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results